Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 2, 2020 (Event Date)
Reporting Period: Specific event date; not a periodic financial report.
Key Financial Metrics and Transaction Details
This filing reports a material capital raising event rather than operational financial performance metrics (revenue, profit, cash flow, or margins are not disclosed in this document).
- Transaction Type: Underwritten public offering of common stock.
- Shares Offered: 8,000,000 shares initially, plus a 30-day option for 1,200,000 additional shares.
- Offering Price: $11.00 per share.
- Option Exercise: Underwriters exercised the option in full on June 3, 2020.
- Total Shares Issued: 9,200,000 shares.
- Net Proceeds: Approximately $94.9 million (after underwriting discounts, commissions, and offering expenses).
- Underwriters: J.P. Morgan Securities LLC, Citigroup Global Markets Inc., and Evercore Group L.L.C. (Joint Book-Running Managers); UBS Securities LLC and Raymond James & Associates, Inc. (Co-Managers).
Material Changes Versus Prior Period
The filing does not provide comparative financial data against prior periods. The material change reported is the execution of a definitive underwriting agreement and the subsequent full exercise of the over-allotment option, resulting in a significant increase in the company's cash liquidity and share count.
Guidance, Outlook, and Risks
Management Commentary: The company expects to receive net proceeds of approximately $94.9 million. Shares were expected to be delivered on or about June 5, 2020, subject to customary closing conditions.
Risks and Contingencies: The closing of the offering is subject to the satisfaction of customary conditions. The filing includes standard representations, warranties, and indemnification rights customary for such transactions.
Unusual Items: None reported beyond the standard terms of the equity offering.
Investor Verification Checklist
- Verify the final closing date and actual delivery of shares (expected June 5, 2020).
- Confirm the exact net proceeds received after all expenses are finalized.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific covenants and lock-up provisions.
- Check subsequent filings for the updated share count and capitalization table.
- Assess the intended use of the $94.9 million in proceeds as disclosed in the related prospectus supplement.